Manufacturers Life Insurance Company, The Phathom Pharmaceuticals, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $106 Billion
- Q2 2025
A detailed history of Manufacturers Life Insurance Company, The transactions in Phathom Pharmaceuticals, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 15,826 shares of PHAT stock, worth $214,600. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,826
Previous 14,462
9.43%
Holding current value
$214,600
Previous $90,000
67.78%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding PHAT
# of Institutions
137Shares Held
60.5MCall Options Held
1.35MPut Options Held
1.19M-
Frazier Life Sciences Management, L.P. Menlo Park, CA12.5MShares$169 Million6.31% of portfolio
-
Medicxi Ventures Management (Jersey) LTD7.46MShares$101 Million12.93% of portfolio
-
Invesco Ltd. Atlanta, GA4.14MShares$56.1 Million0.01% of portfolio
-
Carlyle Group Inc. Washington, DC3.5MShares$47.4 Million41.56% of portfolio
-
Black Rock Inc. New York, NY2.93MShares$39.7 Million0.0% of portfolio
About Phathom Pharmaceuticals, Inc.
- Ticker PHAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,175,200
- Market Cap $531M
- Description
- Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...